Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
Prestigious honor society announces more than 250 new members.
Caroline Uhler blends machine learning, statistics, and biology to understand how our bodies respond to illness.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Study suggests forcing bacteria to burn more energy could make them more susceptible to antibiotics.
Analysis reveals genetic control elements that are linked to hundreds of human traits.
Pablo Jarillo-Herrero, Aviv Regev, Susan Solomon, and Feng Zhang are the recipients of distinguished awards for major contributions to science.
Lander to take a leave of absence to assume Cabinet-level post; Zuber to co-chair presidential advisory council.
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Two MIT faculty members earn funding from the G. Harold and Leila Y. Mathers Foundation.